{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:19:09Z","timestamp":1788135549447,"version":"build-2803163510"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":78,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jagiellonian University Medical College, Poland","award":["N42\/DBS\/000452"],"award-info":[{"award-number":["N42\/DBS\/000452"]}]},{"name":"National Science Centre, Poland","award":["2024\/08\/X\/NZ7\/00479"],"award-info":[{"award-number":["2024\/08\/X\/NZ7\/00479"]}]},{"name":"the Priority Research Area BioS under the Excellence Initiative\u2014Research University program at the Jagiellonian University in Krakow","award":["U1C\/P03\/NO\/03.36"],"award-info":[{"award-number":["U1C\/P03\/NO\/03.36"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-58148-z","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T05:13:30Z","timestamp":1781414010000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Central and peripheral glutamatergic biomarkers delineate heterogeneous clinical phenotypes in olanzapine-treated schizophrenia"],"prefix":"10.1038","volume":"16","author":[{"given":"Wirginia","family":"Krzy\u015bciak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Pilecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Bystrowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Szwajca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"\u015amierciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Turek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Karcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Bryll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gom\u00f3\u0142ka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeusz","family":"Popiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"key":"58148_CR1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.euroneuro.2024.02.005","volume":"82","author":"CU Correll","year":"2024","unstructured":"Correll, C. U. et al. Identification and treatment of individuals with childhood-onset and early-onset schizophrenia. Eur. Neuropsychopharmacol. 82, 57\u201371 (2024).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"58148_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.schres.2017.01.004","volume":"185","author":"CH Lin","year":"2017","unstructured":"Lin, C. H., Wang, F. C., Lin, S. C., Huang, Y. H. & Chen, C. C. A randomized, double-blind, comparison of the efficacy and safety of low-dose olanzapine plus low-dose trifluoperazine versus full-dose olanzapine in the acute treatment of schizophrenia. Schizophr Res. 185, 80\u201387 (2017).","journal-title":"Schizophr Res."},{"key":"58148_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1176\/appi.ajp.2019.19010034","volume":"177","author":"S Leucht","year":"2020","unstructured":"Leucht, S. et al. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia. Am. J. Psychiatry. 177, 342\u2013353 (2020).","journal-title":"Am. J. Psychiatry"},{"key":"58148_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.schres.2024.06.047","volume":"271","author":"P Drosos","year":"2024","unstructured":"Drosos, P. et al. Remission in schizophrenia spectrum disorders: A randomized trial of amisulpride, aripiprazole and olanzapine. Schizophr Res. 271, 9\u201318 (2024).","journal-title":"Schizophr Res."},{"key":"58148_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1001\/archpsyc.55.3.250","volume":"55","author":"GD Tollefson","year":"1998","unstructured":"Tollefson, G. D., Sanger, T. M., Lu, Y. & Thieme, M. E. Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol. Arch. Gen. Psychiatry. 55, 250\u2013258 (1998).","journal-title":"Arch. Gen. Psychiatry"},{"key":"58148_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S2215-0366(23)00366-8","volume":"11","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou, O. et al. Efficacy and effectiveness of antipsychotics in schizophrenia: network meta-analyses combining evidence from randomised controlled trials and real-world data. Lancet Psychiatry. 11, 102\u2013111 (2024).","journal-title":"Lancet Psychiatry"},{"key":"58148_CR7","doi-asserted-by":"crossref","unstructured":"Lang, X., Zang, X., Yu, F. & Xiu, M. Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia. Front Pharmacol. 14, 37153770 (2023).","DOI":"10.3389\/fphar.2023.1166507"},{"key":"58148_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.17650\/2712-7672-2020-1-2-29-42","volume":"1","author":"SN Mosolov","year":"2020","unstructured":"Mosolov, S. N. Diagnosis and treatment depression in schizophrenia. Consortium psychiatricum. 1, 29\u201342 (2020).","journal-title":"Consortium psychiatricum"},{"key":"58148_CR9","first-page":"305","volume":"18","author":"H Silver","year":"2003","unstructured":"Silver, H. Selective serotonin reuptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia. Int. Clin. Psychopharmacol. 18, 305\u2013313 (2003).","journal-title":"Int. Clin. Psychopharmacol."},{"key":"58148_CR10","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1038\/s41380-024-02841-w","volume":"30","author":"L Chen","year":"2025","unstructured":"Chen, L. et al. Refining antipsychotic treatment strategies in schizophrenia: discovery of genetic biomarkers for enhanced drug response prediction. Mol. Psychiatry. 30, 2362\u20132371 (2025).","journal-title":"Mol. Psychiatry"},{"key":"58148_CR11","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00406-013-0399-y","volume":"263","author":"K Hashimoto","year":"2013","unstructured":"Hashimoto, K., Malchow, B., Falkai, P. & Schmitt, A. Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders. Eur. Arch. Psychiatry Clin. Neurosci. 263, 367\u2013377 (2013).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"58148_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/hup.368","volume":"17","author":"RD Oades","year":"2002","unstructured":"Oades, R. D., Klimke, A., Henning, U. & Rao, M. L. Relations of clinical features, subgroups and medication to serum monoamines in schizophrenia. Hum. Psychopharmacology: Clin. Experimental. 17, 15\u201327 (2002).","journal-title":"Hum. Psychopharmacology: Clin. Experimental"},{"key":"58148_CR13","doi-asserted-by":"crossref","unstructured":"Oades, R. D., R\u00f6pcke, B., Henning, U. & Klimke, A. Neuropsychological measures of attention and memory function in schizophrenia: relationships with symptom dimensions and serum monoamine activity. Behav Brain Funct 1, (2005).","DOI":"10.1186\/1744-9081-1-14"},{"key":"58148_CR14","unstructured":"Cohen, J. Statistical Power Analysis for the Behavioral Sciences 2nd edn (Lawrence Erlbaum Associates,, 1988)."},{"key":"58148_CR15","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1136\/bmj.332.7549.1080","volume":"332","author":"DG Altman","year":"2006","unstructured":"Altman, D. G. & Royston, P. The cost of dichotomising continuous variables. BMJ 332, 1080 (2006).","journal-title":"BMJ"},{"key":"58148_CR16","doi-asserted-by":"crossref","unstructured":"Alvarez-Herrera, S. et al. Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia. Pharmaceuticals (Basel). 17(2), 167 (2024).","DOI":"10.3390\/ph17020167"},{"key":"58148_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1176\/ajp.155.7.921","volume":"155","author":"S Kapur","year":"1998","unstructured":"Kapur, S. et al. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation. Am. J. Psychiatry. 155, 921\u2013928 (1998).","journal-title":"Am. J. Psychiatry"},{"key":"58148_CR18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.neuropharm.2015.03.032","volume":"95","author":"N Asaoka","year":"2015","unstructured":"Asaoka, N. et al. Olanzapine augments the effect of selective serotonin reuptake inhibitors by suppressing GABAergic inhibition via antagonism of 5-HT6 receptors in the dorsal raphe nucleus. Neuropharmacology 95, 261\u2013268 (2015).","journal-title":"Neuropharmacology"},{"key":"58148_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.brainresrev.2009.05.005","volume":"61","author":"K Hashimoto","year":"2009","unstructured":"Hashimoto, K. Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res. Rev. 61, 105\u2013123 (2009).","journal-title":"Brain Res. Rev."},{"key":"58148_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","volume":"160","author":"G Sanacora","year":"2003","unstructured":"Sanacora, G. et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am. J. Psychiatry. 160, 577\u2013579 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"58148_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jamapsychiatry.2016.0442","volume":"73","author":"K Merritt","year":"2016","unstructured":"Merritt, K., Egerton, A., Kempton, M. J., Taylor, M. J. & McGuire, P. K. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies. JAMA Psychiatry. 73, 665\u2013674 (2016).","journal-title":"JAMA Psychiatry"},{"key":"58148_CR22","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/s41380-018-0082-9","volume":"23","author":"A Egerton","year":"2018","unstructured":"Egerton, A. et al. Response to initial antipsychotic treatment in first episode psychosis is related to anterior cingulate glutamate levels: a multicentre 1H-MRS study (OPTiMiSE). Mol. Psychiatry. 23, 2145\u20132155 (2018).","journal-title":"Mol. Psychiatry"},{"key":"58148_CR23","doi-asserted-by":"crossref","unstructured":"Lakens, D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 4, (2013).","DOI":"10.3389\/fpsyg.2013.00863"},{"key":"58148_CR24","doi-asserted-by":"crossref","unstructured":"Hawkins, R. A. The blood-brain barrier and glutamate. American J. Clin. Nutrition. 90(3), (2009).","DOI":"10.3945\/ajcn.2009.27462BB"},{"key":"58148_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00726-012-1330-y","volume":"45","author":"JD Fernstrom","year":"2013","unstructured":"Fernstrom, J. D. Large neutral amino acids: dietary effects on brain neurochemistry and function. Amino Acids. 45, 419\u2013430 (2013).","journal-title":"Amino Acids"},{"key":"58148_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1146\/annurev.med.60.042307.110802","volume":"60","author":"M Berger","year":"2009","unstructured":"Berger, M., Gray, J. A. & Roth, B. L. The expanded biology of serotonin. Annu. Rev. Med. 60, 355\u2013366 (2009).","journal-title":"Annu. Rev. Med."},{"key":"58148_CR27","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht, S. et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis. Lancet 382, 951\u2013962 (2013).","journal-title":"Lancet"},{"key":"58148_CR28","doi-asserted-by":"publisher","first-page":"67086","DOI":"10.3389\/fpsyt.2013.00151","volume":"4","author":"K Merritt","year":"2013","unstructured":"Merritt, K., McGuire, P. & Egerton, A. Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis. Front. Psychiatry. 4, 67086 (2013).","journal-title":"Front. Psychiatry"},{"key":"58148_CR29","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3390\/biom10091272","volume":"10","author":"A Bryll","year":"2020","unstructured":"Bryll, A. et al. The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders. Biomolecules 10, 1272 (2020).","journal-title":"Biomolecules"},{"key":"58148_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","volume":"98","author":"LK Bak","year":"2006","unstructured":"Bak, L. K., Schousboe, A. & Waagepetersen, H. S. The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J. Neurochem. 98, 641\u2013653 (2006).","journal-title":"J. Neurochem"},{"key":"58148_CR31","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/schbul\/sbs075","volume":"38","author":"B Moghaddam","year":"2012","unstructured":"Moghaddam, B. & Krystal, J. H. Capturing the Angel in Angel Dust: Twenty Years of Translational Neuroscience Studies of NMDA Receptor Antagonists in Animals and Humans. Schizophr Bull. 38, 942 (2012).","journal-title":"Schizophr Bull."},{"key":"58148_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/JCP.0000000000000770","volume":"37","author":"A Zabala","year":"2017","unstructured":"Zabala, A. et al. A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients. J. Clin. Psychopharmacol. 37, 569\u2013577 (2017).","journal-title":"J. Clin. Psychopharmacol."},{"key":"58148_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0043-116492","volume":"51","author":"C Hiemke","year":"2018","unstructured":"Hiemke, C. et al. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017. Pharmacopsychiatry 51, 9\u201362 (2018).","journal-title":"Pharmacopsychiatry"},{"key":"58148_CR34","doi-asserted-by":"crossref","unstructured":"Kurozumi, H., Uchida, K., Maruta, J., Akada, S. & Inoue, K. Usefulness of Low-Dose Olanzapine for Initial and Maintenance Treatments of Very-Late-Onset Schizophrenia-Like Psychosis: A Case Report. Journal Psychiatry Res. Reviews & Reports. 5(1), 1\u20133 (2023).","DOI":"10.47363\/JPSRR\/2023(5)141"},{"key":"58148_CR35","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3390\/jpm15080380","volume":"15","author":"D Kang","year":"2025","unstructured":"Kang, D., Moon, S., Baek, J. H. & Cho, J. Real-World Evidence on Low-Dose Olanzapine (\u2264\u20091.25\u00a0mg) for Personalized Antipsychotic Dosing. J. Pers. Med. 15, 380 (2025).","journal-title":"J. Pers. Med."},{"key":"58148_CR36","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1001\/jamapsychiatry.2015.0891","volume":"72","author":"A Graff-Guerrero","year":"2015","unstructured":"Graff-Guerrero, A. et al. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2\/3 Receptor Occupancy Study. JAMA Psychiatry. 72, 927\u2013934 (2015).","journal-title":"JAMA Psychiatry"},{"key":"58148_CR37","doi-asserted-by":"crossref","unstructured":"Solhaug, V. et al. The Effect of Age on Antipsychotic Serum Concentration in Males and Females: A Study Based on Therapeutic Drug Monitoring Data From 19,926 Patients. Ther Drug Monit. 47(5), (2025).","DOI":"10.1097\/FTD.0000000000001309"},{"key":"58148_CR38","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/acps.12794","volume":"136","author":"I Castberg","year":"2017","unstructured":"Castberg, I., Westin, A. A., Skogvoll, E. & Spigset, O. Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine. Acta Psychiatr Scand. 136, 455\u2013464 (2017).","journal-title":"Acta Psychiatr Scand."},{"key":"58148_CR39","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","volume":"83","author":"JT Kantrowitz","year":"2010","unstructured":"Kantrowitz, J. T. & Javitt, D. C. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia? Brain Res. Bull. 83, 108\u2013121 (2010).","journal-title":"Brain Res. Bull."},{"key":"58148_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbr069","volume":"39","author":"A Marsman","year":"2013","unstructured":"Marsman, A. et al. Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr Bull. 39, 120\u2013129 (2013).","journal-title":"Schizophr Bull."},{"key":"58148_CR41","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2174\/138920112800784961","volume":"13","author":"A Egerton","year":"2012","unstructured":"Egerton, A. & Stone, M. The glutamate hypothesis of schizophrenia: neuroimaging and drug development. Curr. Pharm. Biotechnol. 13, 1500\u20131512 (2012).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"58148_CR42","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.biopsych.2008.03.004","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk, M. et al. N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia-A Double-Blind, Randomized, Placebo-Controlled Trial. Biol. Psychiatry. 64, 361\u2013368 (2008).","journal-title":"Biol. Psychiatry"},{"key":"58148_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin, O. P. & Mattison, D. R. Sex differences in pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet. 48, 143\u2013157 (2009).","journal-title":"Clin. Pharmacokinet."},{"key":"58148_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuroimage.2012.12.004","volume":"86","author":"PG Mullins","year":"2014","unstructured":"Mullins, P. G. et al. Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. Neuroimage 86, 43\u201352 (2014).","journal-title":"Neuroimage"},{"key":"58148_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","volume":"13","author":"SR Kay","year":"1987","unstructured":"Kay, S. R., Fiszbein, A. & Opler, L. A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 13, 261\u2013276 (1987).","journal-title":"Schizophr Bull."},{"key":"58148_CR46","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1192\/S0007125000292581","volume":"163","author":"D Addington","year":"1993","unstructured":"Addington, D., Addington, J. & Maticka-Tyndale, E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br. J. Psychiatry Suppl. 163, 39\u201344 (1993).","journal-title":"Br. J. Psychiatry Suppl."},{"key":"58148_CR47","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1207\/s15327752jpa6703_13","volume":"67","author":"AT Beck","year":"1996","unstructured":"Beck, A. T., Steer, R. A., Ball, R. & Ranieri, W. F. Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J. Pers. Assess. 67, 588\u2013597 (1996).","journal-title":"J. Pers. Assess."},{"key":"58148_CR48","doi-asserted-by":"crossref","unstructured":"Krzy\u015bciak, W. et al. Association of Blood Metabolomics Biomarkers with Brain Metabolites and Patient-Reported Outcomes as a New Approach in Individualized Diagnosis of Schizophrenia. Int J. Mol. Sci. 25(4), 2294  (2024).","DOI":"10.3390\/ijms25042294"},{"key":"58148_CR49","doi-asserted-by":"crossref","unstructured":"Golonka, K. et al. Sensory processing sensitivity in adult dental patients and its relation to perceived stress, cortisol, and serotonin secretion. Sci. Rep. 15(1), 7328 (2025).","DOI":"10.1038\/s41598-025-90263-1"},{"key":"58148_CR50","doi-asserted-by":"crossref","unstructured":"Shen, Y. et al. Simple and reliable serotonin assay in human serum by LC-MS\/MS method coupled with one step protein precipitation for clinical testing in patients with carcinoid tumors. J Chromatogr. B Analyt Technol. Biomed. Life Sci. 1158, 122395 (2020).","DOI":"10.1016\/j.jchromb.2020.122395"},{"key":"58148_CR51","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1073\/pnas.0809141106","volume":"106","author":"S Whitfield-Gabrieli","year":"2009","unstructured":"Whitfield-Gabrieli, S. et al. Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc. Natl. Acad. Sci. U S A. 106, 1279\u20131284 (2009).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"58148_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02294183","volume":"65","author":"DG Bonett","year":"2000","unstructured":"Bonett, D. G. & Wright, T. A. Sample size requirements for estimating Pearson, Kendall and Spearman correlations. Psychometrika 65, 23\u201328 (2000).","journal-title":"Psychometrika"},{"key":"58148_CR53","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/biomet\/44.3-4.470","volume":"44","author":"EC Fieller","year":"1957","unstructured":"Fieller, E. C., Hartley, H. O. & Pearson, E. S. Tests for rank correlation coefficients. I Biometrika. 44, 470\u2013481 (1957).","journal-title":"I Biometrika"},{"key":"58148_CR54","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjaminit","year":"1995","unstructured":"Benjaminit, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R Stat. Soc. Ser. B Stat. Methodol. 57, 289\u2013300 (1995).","journal-title":"J. R Stat. Soc. Ser. B Stat. Methodol."},{"key":"58148_CR55","unstructured":"Husson, F., Josse, J., Le, S., Mazet, J. & FactoMineR Multivariate exploratory data analysis and data mining. R package version 1.36. https:\/\/CRAN.R-project.org\/package=FactoMineR"},{"key":"58148_CR56","unstructured":"Josse, J. Principal component methods - hierarchical clustering - partitional clustering: why would we need to choose for visualizing data? (2010)."},{"key":"58148_CR57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/BF01908075","volume":"2","author":"L Hubert","year":"1985","unstructured":"Hubert, L. & Arabie, P. Comparing partitions. J. Classif. 2, 193\u2013218 (1985).","journal-title":"J. Classif."},{"key":"58148_CR58","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","volume":"20","author":"PJ Rousseeuw","year":"1987","unstructured":"Rousseeuw, P. J. & Silhouettes A graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 20, 53\u201365 (1987).","journal-title":"J. Comput. Appl. Math."},{"key":"58148_CR59","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. (2024). https:\/\/www.R-project.org\/"},{"key":"58148_CR60","unstructured":"Chan, C., Leeper, T., Becker, J. & Schoch, D. rio: A Swiss-army knife for data file I\/O. (2023). https:\/\/cran.r-project.org\/web\/packages\/rio\/citation.html"},{"key":"58148_CR61","unstructured":"Kassambara, A. & Mundt, F. Extract and Visualize the Results of Multivariate Data Analyses. R package version 1.0.7, (2020). https:\/\/CRAN.R-project.org\/package=factoextra"},{"key":"58148_CR62","unstructured":"Kim, S. Partial and Semi-Partial (Part) Correlation. R package version 1.1, (2015). https:\/\/CRAN.R-project.org\/package=ppcor"},{"key":"58148_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v025.i01","volume":"25","author":"S Le","year":"2008","unstructured":"Le, S., Josse, J., Husson, F. & FactoMineR A Package for Multivariate Analysis. J. Stat. Softw. 25, 1\u201318 (2008).","journal-title":"J. Stat. Softw."},{"key":"58148_CR64","unstructured":"Makowski, D. et al. Automated results reporting as a practical tool to improve reproducibility and methodological best practices adoption.  https:\/\/easystats.github.io\/report\/ (2023)."},{"key":"58148_CR65","unstructured":"Pedersen, T. L. & patchwork The Composer of Plots. R package version 1.2.0, (2024). https:\/\/CRAN.R-project.org\/package=patchwork"},{"key":"58148_CR66","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","volume":"13","author":"DD Sjoberg","year":"2021","unstructured":"Sjoberg, D. D., Whiting, K., Curry, M., Lavery, J. A. & Larmarange, J. Reproducible summary tables with the summary package. R J. 13, 570\u2013580 (2021).","journal-title":"R J."},{"key":"58148_CR67","doi-asserted-by":"crossref","unstructured":"Venables, W. N. & Ripley, B. D. Modern Applied Statistics with S, Fourth Edition (Springer, 2002).","DOI":"10.1007\/978-0-387-21706-2"},{"key":"58148_CR68","unstructured":"Wickham, H. Ggpolt2: Elegant Graphics for Data Analysis. Use R! series (Springer, 2016)."},{"key":"58148_CR69","unstructured":"Wickham, H., Fran\u00e7ois, R., Henry, L., M\u00fcller, K. & Vaughan, D. dplyr: A Grammar of Data Manipulation. R package version 1.1.4, (2023). https:\/\/CRAN.R-project.org\/package=dplyr"},{"key":"58148_CR70","unstructured":"Wickham, H., Vaughan, D. & Girlich, M. Tidy Messy Data. R package version 1.3.1, (2024). https:\/\/CRAN.R-project.org\/package=tidyr"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58148-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58148-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58148-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:09:42Z","timestamp":1788134982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-58148-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["58148"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-58148-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7976871\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,14]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have reviewed and approved the final manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was approved by the Bioethics Committee of the Jagiellonian University, under reference number 1072.6120.87.2024.","order":3,"name":"Ethics","label":"Ethics Declarations","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27136"}}